u/fabio_lehtinen
Contributes reviews on supplier material. Based in Monterrey.
member · joined 15 Jun 2025
Comments — page 3 of 5
comment on reading retatrutide threads from 2024 and half of it aged badly in c/retatrutide · 0 points · 7 months ago
the dosing is steep, the muscle cramps reports are real, and nobody knows the human safety yet
comment on Denmark: ACHIEVE, and what it actually costs here in c/orforglipron · 5 points · 7 months ago
the reflux profile is speculative at this stage
comment on Denmark: ACHIEVE, and what it actually costs here in c/orforglipron · 16 points · 7 months ago
Which country? Half the answers in this thread only apply in France.
comment on small win: TB-500 stopped being a problem at week 21 in c/researchpeptides · 35 points · 7 months ago
the 9-letter analogs are speculative
comment on anyone else notice hypoglycaemia kicking in around week 40 in c/t2dglp1 · 2 points · 7 months ago
Not to be pedantic but hypoglycaemia and metformin are being used interchangeably and they are not interchangeable in real life.
comment on [Question] discontinuation — what am I missing here in c/tapering · 5 points · 8 months ago
Inter-lab variance on this kind of assay is routinely 1–2 points. Different column, different gradient, different integration.
comment on small win: triple agonist stopped being a problem at week 61 in c/retatrutide · 128 points · 8 months ago
the weight curves are unusually steep, which makes predicting individual response harder
comment on what would you tell week-1 you about ATTAIN in c/orforglipron · 50 points · 8 months ago
availability speculation must be flaired Speculation
comment on tracking: the version I wish someone had shown me in week 1 in c/dosinglogs · 19 points · 8 months ago
My version of this: I was so worried about the injection that I put it off for eleven days. The injection is the easiest part.
comment on tracking: the version I wish someone had shown me in week 1 in c/dosinglogs · 1 points · 8 months ago
the people still updating at week 39 are the reward
comment on discontinuation: what the trials say vs what this community says in c/tapering · 48 points · 9 months ago
comment on what changed for me between week 55 and week 3 in c/intlshipping · 1 points · 9 months ago
Customs held the package for 8 days. No problems, just time. Factor it into expectations.
comment on what changed for me between week 55 and week 3 in c/intlshipping · 11 points · 9 months ago
The GGPeps lane used to be 9 days, now averaging 19. Carrier change or route congestion, unclear.
comment on what changed for me between week 55 and week 3 in c/intlshipping · 29 points · 9 months ago
Not to be pedantic but transit time and carrier are being used interchangeably and they are not interchangeable in real life.
comment on is it normal to get fatigue at week 80 in c/t2dglp1 · 10 points · 10 months ago
The reflux was genuinely awful for three weeks and then simply stopped. I know that is not useful information, but it is what happened.
comment on the secretagogue thing finally clicked for me and I want to write it down in c/researchpeptides · 14 points · 10 months ago
Second this question. I have wondered about handling for 2 months and never seen a straight answer.
comment on [Question] triple agonist — what am I missing here in c/retatrutide · 37 points · 10 months ago
This is correct. Triple agonism is genuinely different.
comment on [Results] 71 weeks on 10mg, full numbers, ask me anything boring in c/tapering · 175 points · 10 months ago
cite the discontinuation data rather than guessing regain rates
comment on [PSA] glycaemic control is not what most of this community thinks it is in c/t2dglp1 · -8 points · 11 months ago
no medication-stopping advice, ever
Counter-anecdote: opposite result, same dose. Which mostly tells us the variance is huge.
comment on three years of weekly update threads, summarised so you do not have to read them in c/dosinglogs · 1 points · 11 months ago
the people still updating at week 32 are the reward
Yes, exactly this, and it is the bit that took me 72 weeks to accept.